Literature DB >> 10386163

Analysis of matrix metalloproteinases and related tissue inhibitors in cystic fluids of ovarian tumors.

M Furuya1.   

Abstract

Proteolytic activity of cystic neoplasms of the ovary appears to play a role in destruction of the extracellular matrix and tumor invasion. The purpose of this study was to determine whether the enzymatic activities reflect the degrees of tumor malignancy. The author examined the activity and quantity of matrix metalloproteinases (MMPs) and tissue inhibitors of MMP (TIMPs) in cystic fluids of both benign and malignant epithelial ovarian tumors. The concentration of MMP-9 was statistically higher in mucinous carcinomas (p < 0.05) than in benign ones. TIMP-1, which combines with MMP-9, was also higher (p < 0.05) in malignancies than in benign ones. The ratios of MMP-9/MMP-2 and the concentrations of activated forms of MMPs well associated with the degrees of malignancy, while the mol ratios of TIMP-1/MMP-9 and TIMP-2/MMP-2 inversely correlated. Expressions of MMP-3 and/or trypsin in the fluids were frequently associated with activation of MMP-7 and MMP-9. These observations support the concept that the imbalance of TIMPs/MMPs and the activation of MMPs correlate with the biological malignancy of ovarian cystic tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10386163

Source DB:  PubMed          Journal:  Hokkaido Igaku Zasshi        ISSN: 0367-6102


  4 in total

1.  Progesterone regulation of progesterone receptor membrane component 1 (PGRMC1) sumoylation and transcriptional activity in spontaneously immortalized granulosa cells.

Authors:  John J Peluso; Valentina Lodde; Xiufang Liu
Journal:  Endocrinology       Date:  2012-06-19       Impact factor: 4.736

Review 2.  Ovarian cancer: involvement of the matrix metalloproteinases.

Authors:  Linah Al-Alem; Thomas E Curry
Journal:  Reproduction       Date:  2015-04-27       Impact factor: 3.906

3.  Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.

Authors:  Zhi-Qiang Wang; Magdalena Bachvarova; Chantale Morin; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Dimcho Bachvarov
Journal:  Oncotarget       Date:  2014-01-30

4.  Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation.

Authors:  Hina Mir; Gurpreet Kaur; Neeraj Kapur; Sejong Bae; James W Lillard; Shailesh Singh
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.